Lataa...
Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures
Levetiracetam (LEV) is a relatively newer antiepileptic drug with novel mechanism of action. It was introduced to the market in the year 2000. Pre-marketing clinical trials of the drug reported good tolerability with a wide safety margin. On post-marketing updates, there are few reports of psychosis...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4175900/ https://ncbi.nlm.nih.gov/pubmed/25298593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.140599 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|